Ionis Pharmaceuticals Inc (IONS)
37.23
-0.55
(-1.46%)
USD |
NASDAQ |
Nov 14, 16:00
37.25
+0.02
(+0.05%)
After-Hours: 20:00
Ionis Pharmaceuticals Free Cash Flow (Quarterly): -111.30M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -111.30M |
| June 30, 2024 | -140.14M |
| March 31, 2024 | -155.67M |
| December 31, 2023 | 32.89M |
| September 30, 2023 | -112.26M |
| June 30, 2023 | -110.44M |
| March 31, 2023 | -145.72M |
| December 31, 2022 | -205.20M |
| September 30, 2022 | -31.49M |
| June 30, 2022 | -22.60M |
| March 31, 2022 | -35.18M |
| December 31, 2021 | 199.70M |
| September 30, 2021 | -60.17M |
| June 30, 2021 | -68.96M |
| March 31, 2021 | -57.66M |
| December 31, 2020 | 91.10M |
| September 30, 2020 | -23.25M |
| June 30, 2020 | -55.44M |
| March 31, 2020 | -17.58M |
| December 31, 2019 | 268.90M |
| September 30, 2019 | -30.59M |
| June 30, 2019 | -32.40M |
| March 31, 2019 | 103.44M |
| December 31, 2018 | 113.39M |
| September 30, 2018 | -30.71M |
| Date | Value |
|---|---|
| June 30, 2018 | 492.49M |
| March 31, 2018 | 10.08M |
| December 31, 2017 | 13.34M |
| September 30, 2017 | 8.975M |
| June 30, 2017 | -4.463M |
| March 31, 2017 | 118.44M |
| December 31, 2016 | -30.68M |
| September 30, 2016 | 22.06M |
| June 30, 2016 | -38.23M |
| March 31, 2016 | -76.78M |
| December 31, 2015 | -40.61M |
| September 30, 2015 | 33.29M |
| June 30, 2015 | 61.12M |
| March 31, 2015 | -44.42M |
| December 31, 2014 | 65.99M |
| September 30, 2014 | 0.423M |
| June 30, 2014 | -37.17M |
| March 31, 2014 | -34.06M |
| December 31, 2013 | -16.02M |
| September 30, 2013 | 63.75M |
| June 30, 2013 | 21.90M |
| March 31, 2013 | -11.50M |
| December 31, 2012 | 34.68M |
| September 30, 2012 | -26.23M |
| June 30, 2012 | -4.571M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-205.20M
Minimum
Dec 2022
268.90M
Maximum
Dec 2019
-38.02M
Average
-56.55M
Median
Free Cash Flow (Quarterly) Benchmarks
| Biogen Inc | 805.60M |
| Alnylam Pharmaceuticals Inc | 39.52M |
| Biomarin Pharmaceutical Inc | 200.30M |
| Amicus Therapeutics Inc | -23.33M |
| Arbutus Biopharma Corp | -20.74M |